SEC Form 4 · accession 0001179110-18-013647
OMNICELL, INC. · OMCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter J. Kuipers
Officer — Executive V P& CFO
Period of report
Dec 10, 2018
Accepted (ET)
Dec 10, 2018 · 6:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000926326
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 10, 2018 | M | 5,574 | $0.00 | A | 57,116 | D | |
| Common StockF2 | Dec 10, 2018 | S | 2,343 | $70.1284 | D | 54,773 | D | |
| Common StockF3 | Dec 10, 2018 | S | 1,086 | $70.1318 | D | 53,687 | D | |
| Common StockF4 | Dec 10, 2018 | S | 261 | $69.78 | D | 53,426 | D | |
| Common StockF5 | Dec 10, 2018 | S | 1,884 | $70.1237 | D | 51,542 | D | |
| Common Stock | holding | — | — | — | 51,542 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options NQ (Right to Buy)F1 | $32.78 | Dec 10, 2018 | M | 2,343 | D | Sep 1, 2016 | Sep 1, 2025 | Common Stock | 2,343 | 2,373 | D |
| Stock Options NQ (Right to Buy)F1 | $27.70 | Dec 10, 2018 | M | 1,086 | D | Feb 4, 2017 | Feb 4, 2027 | Common Stock | 1,086 | 1,086 | D |
| Stock Options NQ (Right to Buy)F1 | $36.70 | Dec 10, 2018 | M | 261 | D | Feb 8, 2018 | Feb 8, 2027 | Common Stock | 261 | 261 | D |
| Stock Options NQ (Right to Buy)F1 | $36.70 | Dec 10, 2018 | M | 1,884 | D | Feb 8, 2018 | Feb 8, 2027 | Common Stock | 1,884 | 1,884 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.
- F2The price reported in Column 4 is the average price of $70.1284. The shares sold between $69.20 to $71.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The price reported in Column 4 is the average price of $70.1318. The sold price range was between $69.20 to $71.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4The price reported in Column 4 is the exact price of $69.78. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5The price reported in Column 4 is the average price of $70.1237. The sold price range was between $69.20 to $71.43. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.